US Patent 11225496 Chelated PSMA inhibitors
Patent 11225496 was granted and assigned to Cancer Targeted Technology on January, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11225496 Chelated PSMA inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
